Breaking News Instant updates and real-time market news.

NUS

Nu Skin

$49.35

-2.57 (-4.95%)

06:32
03/25/19
03/25
06:32
03/25/19
06:32

Nu Skin downgraded to Sell from Hold at Stifel

Stifel analyst Mark Astrachan downgraded Nu Skin Enterprises to Sell from Hold and cut his price target for the shares to $43 from $63. The analyst sees increasing uncertainty surrounding direct selling companies in China relating to the investigation announced in January into the unlawful promotion and sale of health products. Further, the recent death of a Nu Skin registered customer who refused medical treatment believing company products would treat illness resulted in the company being cited in two communist party publications, Beijing Youth Daily and China Daily, with the latter calling for an investigation into the woman's death and Nu Skin's misleading advertising, Astrachan tells investors in a research note. The analyst admits he's unable to determine whether an investigation will be undertaken, but he says the mention in prominent party publications is reminiscent of events in 2014 that ultimately resulted in Nu Skin suspending meetings and recruitment, resulting in sales declines for two years in China. Astrachan cites increasing regulatory concerns in China for his downgrade of Nu Skin shares to Sell.

NUS Nu Skin
$49.35

-2.57 (-4.95%)

10/09/18
DADA
10/09/18
INITIATION
Target $92
DADA
Buy
Nu Skin initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Nu Skin (NUS) with a Buy rating and a price target of $92, forecasting a 13% organic sales growth and 24% earnings growth in FY18. The analyst notes the achievements of the company's new CEO and CFO in shifting its focus to customer acquisition through "engaging Platforms that leverage social selling, enabling Products that are demonstrable online, and empowering programs to optimize sales performance." Weiser also points to Nu Skin's attractive valuation at 9.0-times her expected FY19 EBITDA - a discount to Herbalife (HLF) and USANA (USNA) which trade around 11-times.
10/10/18
10/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Take-Two (TTWO) initiated with an Outperform at Bernstein. 2. Shake Shack (SHAK) initiated with a Hold at Stifel. 3. Nu Skin (NUS) initiated with a Buy at DA Davidson. 4. Micron (MU) initiated with a Neutral at Piper Jaffray. 5. Crispr Therapeutics (CRSP) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/21/18
TIGR
11/21/18
NO CHANGE
TIGR
Strong Buy
Nu Skin pullback a buying opportunity, says Tigress Financial
Tigress Financial analyst Ivan Feinseth said he views the recent pullback in shares of Nu Skin as a buying opportunity, citing his belief that the company will continue to benefit from the growing global trend of entrepreneurialism and the global aging population. He reiterates his Strong Buy rating on Nu Skin shares.
12/12/18
DADA
12/12/18
NO CHANGE
Target $88
DADA
Buy
Nu Skin price target lowered to $88 from $92 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on Nu Skin to $88 after meeting with its CFO Mark Lawrence in a Holiday Beauty Bus Tour. The analyst states that while he was upbeat about the company's 3-pillar growth strategy around "Platforms, Products, and Programs", her lower price target is driven by the assumption of lower 2019 gross margins as the company's "lower margin manufacturing operations are likely to grow faster than the overall business". Weiser also lowers her FY19 EPS view by 15c to $4.00 but maintains a Buy rating on Nu Skin shares longer term on expectations that the company will gradually phase out its "limited time offers", thereby reducing the lumpiness of its sales growth rate.

TODAY'S FREE FLY STORIES

FRTA

Forterra

$10.69

0.11 (1.04%)

16:46
12/13/19
12/13
16:46
12/13/19
16:46
Syndicate
Breaking Syndicate news story on Forterra »

Forterra files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:45
12/13/19
12/13
16:45
12/13/19
16:45
Hot Stocks
Amarin receives FDA approval of Vascepa »

The U.S. FDA approved the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

, SPX

S&P 500

$0.00

(0.00%)

16:37
12/13/19
12/13
16:37
12/13/19
16:37
Periodicals
SCOTUS to hear three cases on Trump's financial records, CNBC reports »

The U.S. Supreme Court…

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$204.61

1.47 (0.72%)

16:34
12/13/19
12/13
16:34
12/13/19
16:34
Hot Stocks
CME Group CEO Duffy sells 39,309 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GLG

China Bat Group

$1.81

-0.055 (-2.95%)

16:33
12/13/19
12/13
16:33
12/13/19
16:33
Hot Stocks
China Bat Group regains compliance with Nasdaq »

China Bat Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

16:32
12/13/19
12/13
16:32
12/13/19
16:32
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HZNP

Horizon Pharma

$32.84

(0.00%)

16:30
12/13/19
12/13
16:30
12/13/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

16:30
12/13/19
12/13
16:30
12/13/19
16:30
Options
Preliminary option volume of 31.3M today »

Preliminary option volume…

ORCL

Oracle

$54.49

-1.98 (-3.51%)

, ADBE

Adobe

$316.89

11.13 (3.64%)

16:27
12/13/19
12/13
16:27
12/13/19
16:27
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks were on a…

ORCL

Oracle

$54.49

-1.98 (-3.51%)

ADBE

Adobe

$316.89

11.13 (3.64%)

RBS

RBS

$6.81

0.65 (10.55%)

BCS

Barclays

$9.73

0.65 (7.16%)

LYG

Lloyds Banking

$3.43

0.235 (7.37%)

T

AT&T

$38.24

-0.11 (-0.29%)

LYV

Live Nation

$64.23

-5.21 (-7.50%)

SRPT

Sarepta

$132.00

31.61 (31.49%)

TNDM

TNDM

ATNX

Athenex

$14.56

-2.38 (-14.05%)

AVGO

Broadcom

$315.37

-12.02 (-3.67%)

COST

Costco

$291.88

-5.62 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 29

    Jan

  • 05

    Mar

VKTX

Viking Therapeutics

$7.94

0.045 (0.57%)

16:26
12/13/19
12/13
16:26
12/13/19
16:26
Conference/Events
Viking Therapeutics management to meet with SVB Leerink »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

VCYT

Veracyte

$28.50

-0.16 (-0.56%)

16:24
12/13/19
12/13
16:24
12/13/19
16:24
Conference/Events
Veracyte management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

MCK

McKesson

$140.56

-3.44 (-2.39%)

16:21
12/13/19
12/13
16:21
12/13/19
16:21
Conference/Events
McKessonto hold a sell-side analyst meeting »

Sell-Side Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MDR

McDermott

$0.82

0.0412 (5.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Hot Stocks
McDermott discloses NYSE delisting notice »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.26

-1.52 (-1.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 26

    Mar

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 13th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPWR

Ideal Power

$2.45

0.04 (1.66%)

16:19
12/13/19
12/13
16:19
12/13/19
16:19
Syndicate
Breaking Syndicate news story on Ideal Power »

Ideal Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIE

Erie Indemnity

$168.97

0.25 (0.15%)

16:18
12/13/19
12/13
16:18
12/13/19
16:18
Hot Stocks
Erie Indemnity increases quarterly dividend »

The board of Erie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ESRT

Empire State Realty

$13.68

0.055 (0.40%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Empire State Realty renews $500M stock repurchase program »

Empire State Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.95

0.09 (0.50%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Host Hotels declares special dividend of 5c per share »

Host Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
12/13/19
12/13
16:16
12/13/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACW

PacWest Bancorp

$38.11

-0.54 (-1.40%)

16:14
12/13/19
12/13
16:14
12/13/19
16:14
Hot Stocks
PacWest Bancorp CEO buys 6.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.03

-1.75 (-1.51%)

16:13
12/13/19
12/13
16:13
12/13/19
16:13
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

OC

Owens Corning

$64.62

-1.03 (-1.57%)

16:13
12/13/19
12/13
16:13
12/13/19
16:13
Hot Stocks
Owens Corning exec chairman Thaman sells 30,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRR

Carbo Ceramics

$0.42

0.0132 (3.21%)

16:11
12/13/19
12/13
16:11
12/13/19
16:11
Hot Stocks
Carbo Ceramics to delist from NYSE, applies to list on OTCQB market »

CARBO Ceramics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.